
Xencor Inc
XNCRNASDAQ NMS - GLOBAL MARKETKey Statistics
Open
$11.97
Day High
$12.22
Day Low
$11.75
Prev. Close
$11.97
VolumeShares traded today.
613.53K
Avg. VolumeAverage daily volume.
—
Market CapTotal value of all shares = price × shares outstanding.
$880.80M
P/E (TTM)Price-to-Earnings: share price ÷ earnings per share over the last 12 months. Lower can mean cheaper; very high can mean growth expectations.
-5.17
Forward P/EP/E based on forecast next-year earnings.
—
P/B RatioPrice-to-Book: share price ÷ book value per share.
—
52W HighHighest price over the past 52 weeks.
$18.69
52W LowLowest price over the past 52 weeks.
$6.92
50D MAAverage closing price over the last 50 trading days.
$12.21
200D MAAverage closing price over the last 200 trading days.
$12.58
Dividend YieldAnnual dividend ÷ share price, as a %.
—
BetaVolatility vs the market. >1 = more volatile than the S&P 500.
—
Performance
1W
+5.4%1M
+2.2%6M
-31.2%YTD
-20.4%1Y
+48.5%About
MorphoSys AG is a German biopharmaceutical company founded in 1992. The company is headquartered near Munich, Germany, and has a wholly owned subsidiary, MorphoSys US Inc., in Boston, Massachusetts, in the US. The company has various antibody, protein and peptide technologies that it uses to discover and develop both proprietary and partnered drug candidates. The company has more than 100 drugs in its wider pipeline that are being investigated as treatments for a variety of diseases. While many of these are being developed in partnership with pharma and biotech companies, MorphoSys also has a proprietary pipeline with a focus on cancer and autoimmune diseases.
xencor.com/Company Facts
Similar stocks
Health CareSentiment
Latest News
Social Noise
Price Alerts
Loading…
Trade XNCR
Brokers available in your region (US)
Affiliate links — we may earn a commission. CFDs are risky.